Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Royal Pharmaceuticals, Inc. is a specialty pharmaceutical company based in New Jersey that focuses on the commercialization, marketing, and distribution of FDA-approved prescription drugs. The company is primarily recognized for its portfolio in dermatology and pediatrics, featuring well-known brands such as Derma-Smoothe/FS (fluocinolone acetonide) for scalp psoriasis and atopic dermatitis, and Pediapred (prednisolone sodium phosphate) for various inflammatory and allergic disorders. Royal Pharmaceuticals often operates as a labeling and marketing partner for products manufactured by Hill Dermaceuticals, ensuring their availability across national wholesale distributors, retail chains, and health systems. The company maintains a strong presence in the niche specialty markets of topical corticosteroids and pediatric oral solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Royal Pharmaceuticals.